Presentation is loading. Please wait.

Presentation is loading. Please wait.

Aortic Stenosis Echo Clinical Conference March 10, 2010 Anne B. Riley.

Similar presentations


Presentation on theme: "Aortic Stenosis Echo Clinical Conference March 10, 2010 Anne B. Riley."— Presentation transcript:

1 Aortic Stenosis Echo Clinical Conference March 10, 2010 Anne B. Riley

2 Outline Epidemiology Etiology Disease Course Imaging evaluation Management New Technologies

3 Epidemiology Common disease: In a population-based echocardiographic study, 2% of persons 65 years of age or older had frank calcific AS, 29% exhibited age-related aortic valve sclerosis without stenosis Bicuspid valves present in 1-2% of population Calcific valve disease, even in the absence of valve obstruction, is associated with a 50% increased risk of CV death and MI Braunwald’s Heart Disease.

4 Etiology A. Normal Valve B. Congenital Bicuspid valve C. Rheumatic aortic stenosis D. Calcific degenerative AS

5 Calcific Aortic Stenosis Lipocalcific changes on aortic side of cusp Sparing of commissures Mechanical stress: highest at aortic side in the flexion area, near attachment to aortic root

6 Calcific Aortic Stenosis: Pathology Cells, lipid and matrix in subendothelial location, elastic lamina displaced Greater accumulation of cells, lipid and matrix in subendothelial location, elastic lamina fragmented Freeman, et al. Spectrum of Calcific Aortic Valve Disease: Pathogenesis, Disease Progression, and Treatment Strategies. Circulation 2005.

7 Calcific AS: Pathogenesis Lipid accumulation Inflammation Calcification Freeman, et al. Spectrum of Calcific Aortic Valve Disease: Pathogenesis, Disease Progression, and Treatment Strategies. Circulation 2005.

8 Bicuspid valves Exist in 1-2% of the populuation More prevalent in men (70-80% of cases) Subset of bicuspids have autosomal dominant inheritance with incomplete penetrance Have associated dilatation of the ascending aorta (unrelated to degree of AS or AR), related to abnormalities of the media Histopathology of calcific stenosis of a bicupsid valve is the same as that of a trileaflet valve Increased turbulent flow and leaflet stress is felt to accelerate the changes-> earlier age of presentation (about 20 years earlier)

9 Roberts WC et al. Frequency by Decades of Unicuspid, Bicuspid, and Tricuspid Aortic Valves in Adults Having Isolated Aortic Valve Replacement for Aortic Stenosis, With or Without Associated Aortic Regurgitation. Circulation MenNo (%) Unicuspid 34 (6) Bicuspid 309 (53) Tricuspid 234 (40) Uncertain 7 (1) Subtotal 584 (100) Women Unicuspid 12 (3) Bicuspid 149 (43) Tricuspid 183 (53) Uncertain 4 (1) Subtotal 348 (100) Time period: January 1993 through June 2004, Baylor University Procedure: AVR for isolated aortic stenosis Exclusions: Mitral valve replacement or mitral stenosis, previous aortic valvoplasty RESULTS: Age <50 (7% of patients) 2/3 bicuspid, 1/3 unicuspid Age (40% of patients) 2/3 bicuspid, 1/3 tricuspid Age >70 (53% of patients) 2/5 bicuspid, 3/5 tricuspid Bicuspid Valves: Very Common reason for AVR

10 Rheumatic Heart Disease Fusion of commissures between the leaflets and leaflet vascularization-> leads to retraction and stiffening of free borders of the cusps Small round or triangular opening Calcific nodules develop on both surfaces Often have AI and AS Usually involves the mitral valve as well Valve often regurgitant and stenotic

11 Aortic Stenosis: Disease Course Onset of symptoms to time of death Heart failure: 2 years Syncope: 3 years Angina: 5 years

12 Hemodynamic progression Valve area0.12 cm2/yr Aortic jet velocity0.32 m/sec/yr Mean gradient increase7 mm Hg/yr

13 Predicting Events Rosenhek, R. et al. The Natural History of Very Severe Aortic Stenosis. Circulation 2010;121:

14 Evaluation Echocardiography – M mode – 2-D imaging – Doppler Cardiac Catheterization

15 Echocardiography: M mode Dense persistent echoes Obscures normal leaflet motion

16 Two Dimensional Echocardiography Look for… – Extent of calcification of the leaflets and the aortic root (including the aortic ring) – Degree and pattern of leaflet motion Doming pattern, asymmetric closure (? Bicuspid valve) – Post-stenotic dilatation of the aortic root – LVH

17 Doppler Echocardiography: Velocity Continuous wave doppler from multiple sites to sample flow across the valve To get highest velocity: need angle of interrogation to be as parallel with flow as possible Angles greater than 30 degrees result in major underestimation

18 From Velocity to Pressure: Bernoulli Equation ΔP = ½ p (v v 1 2 ) + p (dv/dt)dx + R(v) ΔPPressure gradient across valve (mm Hg) p Mass density of blood (1.06 x 10 3 kg/m 3 ) v 2 Velocity in stenotic jet v 1 Velocity proximal to stenosis (dv/dt)dxTime-varying velocity at each distance along flowstream R(v)Constant for viscous resistance

19 Modified Bernoulli Simplified Bernoulli equation to obtain peak instantaneous gradient Peak pressure gradient= 4 x peak velocity²

20 Mean Pressure Gradient ΔP mean = ΔP max / mm Hg Mean gradient is approximately 2/3 of the peak instantaneous gradient Most often obtained by planimetry of the Doppler envelope

21 Doppler Echocardiography Non-invasive assessment of aortic stenosis by Doppler Ultrasound. L Hatle et al. 1980; “In 57 of 63 patients with aortic stenosis, the aortic jet could be reached by the ultrasound beam and, in 37 of these, peak pressure drop by ultrasound was compared with that obtained at catheterization. In patients less than 50 years of age the aortic jet was easy to find, the measurement was reproducible, and underestimation of the pressure drop obtained at catheterization was within 25 per cent in 17 of 18 patients. In patients over 50 years Doppler signals from the aortic jet were more difficult to obtain, and pressure drop was significantly underestimated in one-third, but time of maximum velocity in systole could indicate whether moderate or severe aortic stenosis was present. “

22 Velocity and AVA Vmax (m/s) Severity >4 Severe 3-4 Moderate Mild <1.5 Normal 2006 AHA/ACC Guidelines

23 AVA: Continuity Equation SV=Cross Sectional Area * TVI AVA= CSAot * TVI ot/TVI av CSA =  r² Simplified continuity equation: AVA= CSA ot * Vot/Vav Stroke volume proximal to aortic valve must equal the stroke volume through the stenotic orifice

24 Bernoulli alone vs. Continuity Equation Increasing stroke volume increases the gradient – Coexisting AR – Hyperdynamic LV function Decreasing stroke volume decreases the gradient even in presence of severe stenosis – Severe LV dysfunction – Coexisting MR Continuity equation should not be affected

25 Case Example

26

27

28

29

30 Cardiac Catheterization Otto. Textbook of Clinical Echocardiography. Measures peak to peak gradients vs. Dopplers instantaneous gradients Peak to peak gradients never actually exist Mean gradients correlate better between cath and echo

31 Gorlin Equation AVA (cm²) = CO ÷ [44.3 x SEP x HR x  ΔP] SV = stroke volume (mL per beat) SEP = systolic ejection period (sec per beat) ΔP = mean systolic pressure gradient between the left ventricle and aorta (mmHg)

32 Echo challenges The Aortic Jet Search for the highest frequency signal- assumed to present the nearest-parallel angle between the ultrasound in the direction of the jet Intercept angles within 15 degrees of parallel result in error of velocity of <5% Pitfalls: Inability to align the interrogation angle parallel to flow, mistakenly identify the jet (MR, TR, VSD, PA stenosis, Subaortic stenosis) Variability in velocity in irregular heart rhythms (afib, PVCs)

33 Echo Challenges (cont) Outflow tract diameter Measured in mid-systole, just proximal to and parallel to the plane of the stenotic AV from the inner edge of the septal endocardial echo to the leading edge of the base of the anterior mitral leaflet Parasternal long axis view This measurement shows the greatest intraoberver and interobserver variability Small errors in measurement lead to larger errors in CSA

34 Echo Challenges (cont) Outflow tract velocity Measured using pulsed doppler echo Outflow tract diameter and velocity signals need to be recorded at the same anatomic site Measure both immediately adjacent to the valve

35 Therapy: Medical

36 The Statin Story SALTIRE Trial: Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (NEJM 2005) – 155 calcific AS patients (aortic jet velocity>2.5 m/s, calcification seen on TTE, mean AVA 1.03 cm 2 ) – Randomized to atorvastatin 80 mg vs. placebo – Endpoints: change in aortic jet velocity and aortic valve calcium score – 25 month follow up: no difference in progression of aortic valve calcification or rate of increase in aortic jet velocity RAAVE Study: Rosuvastatin Affecting Aortic Valve Endothelium (JACC 2007) – 121 patients with moderate to severe AS – Non-random assignment to rosuvastatin 20 mg if LDL > 130 mg/dL or to no statin if LDL < 130 mg/dL – Endpoints: aortic valve area, aortic jet velocity – 73 weeks follow up, patients treated with rosuvastatin had significantly slower rates of deterioration in mean aortic valve area and aortic jet velocity

37 Statins, continued SEAS Trial: Simvastatin and Ezetimibe in Aortic Stenosis (NEJM adults with mild to moderate aortic stenosis Randomly assigned to treatment with simvastatin 40 mg plus ezetimibe 10 mg or placebo At 52 months follow up: no difference in the primary endpoint: CV death, AVR, non-fatal MI, hospitalized unstable angina, CHF as a result of progression of AS, CABG, PCI, and non-hemorrhagic stroke. No difference in the rate of aortic valve replacement (28 versus 30 percent) or in the rate of hemodynamic progression of aortic stenosis Fewer ischemic events in the treatment group, due to a lower rate of CABG at the time of aortic valve surgery Higher rate of cancers in simvastatin-ezetimibe group

38 Therapy : Surgical ACC/AHA 2006 guidelines

39 Up and Comers: Medtronic CoreValve ® Aortic porcine trileaflet valve on self-expanding frame Perform valvuloplasty first, then deploy valve Delivered through an 18 French catheter US clinical trial scheduled to start Summer 2010

40 Medtronic CoreValve

41 Edwards SAPIEN TM Percutaneous Valve Equine pericardial trileaflet valve is sewn within a stainless steel frame Deployed via transfemoral or transapical approach Balloon inflation used to deploy the valve PARTNER trial underway

42


Download ppt "Aortic Stenosis Echo Clinical Conference March 10, 2010 Anne B. Riley."

Similar presentations


Ads by Google